circ-NOL10 regulated by MTDH/CASC3 inhibits breast cancer progression and metastasis via multiple miRNAs and PDCD4.
circ-NOL10 regulated by MTDH/CASC3 inhibits breast cancer progression and metastasis via multiple miRNAs and PDCD4.
复制标题
DOI:
10.1016/j.omtn.2021.09.013
复制
发表时间:
2021-12-03
期刊:
影响因子:
--
通讯作者:
Xu J
中科院分区:
文献类型:
--
作者:
Cai Y;Zhao X;Chen D;Zhang F;Chen Q;Shao CC;Ouyang YX;Feng J;Cui L;Chen M;Xu J
Circular RNAs (circRNAs) play important roles in carcinogenesis. Here, we investigated the mechanisms and clinical significance of circ-NOL10, a highly repressed circRNA in breast cancer. Subsequently, we also identified RNA-binding proteins (RBPs) that regulate circ-NOL10. Bioinformatics analysis was utilized to predict regulatory RBPs as well as circ-NOL10 downstream microRNAs (miRNAs) and mRNA targets. RNA immunoprecipitation, luciferase assay, fluorescence in situ hybridization, cell proliferation, wound healing, Matrigel invasion, cell apoptosis assays, and a xenograft model were used to investigate the function and mechanisms of circ-NOL10 in vitro and in vivo. The clinical value of circ-NOL10 was evaluated in a large cohort of breast cancer by quantitative real-time PCR. Circ-NOL10 is downregulated in breast cancer and associated with aggressive characteristics and shorter survival time. Upregulation of circ-NOL10 promotes apoptosis, decreases proliferation, and inhibits invasion and migration. Furthermore, circ-NOL10 binds multiple miRNAs to alleviate carcinogenesis by regulating PDCD4. CASC3 and metadherin (MTDH) can bind directly to circ-NOL10 with characterized motifs. Accordingly, ectopic expression or depletion of CASC3 or MTDH leads to circ-NOL10 expression changes, suggesting that these two RBPs modulate circ-NOL10 in cancer cells. circ-NOL10 is a novel biomarker for diagnosis and prognosis in breast cancer. These results highlight the importance of therapeutic targeting of the RBP-noncoding RNA (ncRNA) regulation network. A novel RBP-ncRNA signaling route, formed by two RBPs (MTDH and CASC3), one circRNA (circ-NOL10), three miRNAs (miR-149-5p, miR-330-3p, and miR-452-5p), and the effector PDCD4, is identified. This investigation reveals a ncRNA-mediated mechanism in breast cancer carcinogenesis and provides novel insights for therapeutic targeting of ncRNAs.
登录
查看更多内容
影响因子:
14.9
作者:
Cho S;Jang I;Jun Y;Yoon S;Ko M;Kwon Y;Choi I;Chang H;Ryu D;Lee B;Kim VN;Kim W;Lee S
通讯作者:
Lee S
DOI:
10.1186/s13046-019-1398-2
发表时间:
2019-09-05
影响因子:
11.3
作者:
Ren, Shasha;Liu, Jiuzhou;Zhang, Yanwu
通讯作者:
Zhang, Yanwu
影响因子:
11.2
作者:
Robertson CL;Mendoza RG;Jariwala N;Dozmorov M;Mukhopadhyay ND;Subler MA;Windle JJ;Lai Z;Fisher PB;Ghosh S;Sarkar D
通讯作者:
Sarkar D
DOI:
10.1186/bcr3343
发表时间:
2012-10-26
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Meric-Bernstam F;Chen H;Akcakanat A;Do KA;Lluch A;Hennessy BT;Hortobagyi GN;Mills GB;Gonzalez-Angulo A
通讯作者:
Gonzalez-Angulo A
影响因子:
4.1
作者:
Dudekulay, Dawood B.;Panda, Amaresh C.;Gorospe, Myriam
通讯作者:
Gorospe, Myriam